Erythropoietin after bone marrow transplantation.
The anemia associated with bone marrow transplantation is in part related to a relative erythropoietin deficiency. Recombinant human erythropoietin has been studied in different clinical situations. After allogenic bone marrow transplant, recombinant human erythropoietin has enhanced erythroid engraftment and in several studies, decreased transfusion requirement.
Miller
C B
CB
Johns Hopkins Oncology Center, Baltimore, Maryland.
Mills
S
S
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D004921:Erythropoietin